COMMONWEALTH INDUSTRIES INC/DE/
S-3/A, 1997-09-19
ROLLING DRAWING & EXTRUDING OF NONFERROUS METALS
Previous: MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC, 497, 1997-09-19
Next: PROGENITOR INC, 10-Q, 1997-09-19



<PAGE>
   
   AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON SEPTEMBER 18, 1997
    
 
                                                      REGISTRATION NO. 333-32541
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
 
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                            ------------------------
 
   
                                AMENDMENT NO. 2
                                       TO
    
 
                                    FORM S-3
                             REGISTRATION STATEMENT
                                     UNDER
                           THE SECURITIES ACT OF 1933
                            ------------------------
 
                         COMMONWEALTH INDUSTRIES, INC.
             (Exact name of Registrant as specified in its charter)
 
<TABLE>
<S>                                                             <C>
                           DELAWARE                                                       13-3245741
               (State or other jurisdiction of                                         (I.R.S. Employer
                incorporation or organization)                                      Identification Number)
</TABLE>
 
                     500 WEST JEFFERSON STREET, 19TH FLOOR
                        LOUISVILLE, KENTUCKY 40202-2823
                                 (502) 589-8100
         (Address, including zip code, and telephone number, including
            area code, of Registrant's principal executive offices)
 
                         ------------------------------
 
                                MARK V. KAMINSKI
                     PRESIDENT AND CHIEF EXECUTIVE OFFICER
                         COMMONWEALTH INDUSTRIES, INC.
                     500 WEST JEFFERSON STREET, 19TH FLOOR
                        LOUISVILLE, KENTUCKY 40202-2823
                                 (502) 589-8100
           (Name, address, including zip code, and telephone number,
                   including area code, of agent for service)
 
                         ------------------------------
 
                                   Copies to:
 
<TABLE>
<S>                                          <C>
             ROBERT W. DOWNES                          WINTHROP B. CONRAD, JR.
            SULLIVAN & CROMWELL                         DAVIS POLK & WARDWELL
             125 BROAD STREET                           450 LEXINGTON AVENUE
       NEW YORK, NEW YORK 10004-2498                  NEW YORK, NEW YORK 10017
</TABLE>
 
                            ------------------------
 
        APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:
 
   AS SOON AS PRACTICABLE ON OR AFTER THE EFFECTIVE DATE OF THIS REGISTRATION
                                   STATEMENT.
 
    If the only securities being registered on this form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box. / /
 
    If any of the securities being registered on this form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. / /
 
    If this form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. / /
- --------
 
    If this form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. / /
- --------
 
    If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. / /
 
                           --------------------------
 
    THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION
STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF
THE SECURITIES ACT OF 1933 OR UNTIL THIS REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE SECURITIES AND EXCHANGE COMMISSION, ACTING
PURSUANT TO SAID SECTION 8(A), MAY DETERMINE.
 
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
                                    PART II
 
                     INFORMATION NOT REQUIRED IN PROSPECTUS
 
ITEM 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION*
 
    The following are the estimated expenses of the issuance and distribution of
the securities being registered, all of which will be paid by the Company.
 
   
<TABLE>
<CAPTION>
<S>                                                 <C>
SEC registration fee..............................  $  35,176
NASD filing fee...................................     12,000
Blue sky fees and expenses........................      5,000
Printing and engraving expenses...................    150,000
Legal fees and expenses...........................    200,000
Accounting fees and expenses......................     75,000
Miscellaneous.....................................    122,824
                                                    ---------
      Total.......................................  $ 600,000
                                                    ---------
                                                    ---------
</TABLE>
    
 
- ------------------------
 
* All amounts are estimated except for the SEC registration fee and NASD filing
fee.
 
ITEM 15. INDEMNIFICATION OF OFFICERS AND DIRECTORS
 
    Section 145 of the Delaware General Corporation Law provides that a
corporation may indemnify directors and officers as well as other employees and
individuals against expenses (including attorneys' fees), judgments, fines and
amounts paid in settlement in connection with specified actions, suits or
proceedings, whether civil, criminal, administrative or investigative (other
than an action by or in the right of the corporation--a "derivative action"), if
they acted in good faith and in a manner they reasonably believed to be in or
not opposed to the best interests of the corporation, and, with respect to any
criminal action or proceeding, had no reasonable cause to believe their conduct
was unlawful. A similar standard is applicable in the case of derivative
actions, except that indemnification only extends to expenses (including
attorneys' fees) incurred in connection with the defense or settlement of such
action, and the statute requires court approval before there can be any
indemnification where the person seeking indemnification has been found liable
to the corporation. The statute provides that it is not exclusive of other
rights to which those seeking indemnification may be entitled under any by-law,
agreement, vote of stockholders or disinterested directors or otherwise. The
Company's By-Laws provide that the Company shall indemnify its directors and
officers to the fullest extent permitted by Delaware law.
 
    Section 102(b)(7) of the Delaware General Corporation Law permits a
corporation to provide in its certificate of incorporation that a director of
the corporation shall not be personally liable to the corporation or its
stockholders for monetary damages for breach of fiduciary duty as a director,
except for liability (i) for any breach of the director's duty of loyalty to the
corporation or its stockholders, (ii) for acts or omissions not in good faith or
which involve intentional misconduct or a knowing violation of law, (iii) for
payments of unlawful dividends or unlawful stock repurchases or redemptions, or
(iv) for any transaction from which the director derived an improper personal
benefit. The Company's Certificate of Incorporation provides for such limitation
of liability.
 
    Reference is also made to Section 7 of the Underwriting Agreement to be
filed as Exhibit 1.1 to the Registration Statement for information concerning
the Underwriters' obligation to indemnify the Registrant and its officers and
directors in certain circumstances.
 
                                      II-1
<PAGE>
ITEM 16. EXHIBITS
 
   
<TABLE>
<CAPTION>
<S>        <C>
1.1        Form of Underwriting Agreement.
 
4.1        Restated Certificate of Incorporation, effective April 18, 1997 (incorporated by
           reference to Exhibit 3.1 to the Company's Quarterly Report on Form 10-Q for the
           quarter ended March 31, 1997).
 
4.2        By-Laws (incorporated by reference to Exhibit 3.3 to the Company's Registration
           Statement No. 33-87294 on Form S-1).
 
4.3        Stockholder Protection Rights Agreement, dated as of March 6, 1996, including forms of
           Rights Certificate, Election to Exercise and Certificate of Designation and Terms of
           Participating Preferred Stock of the Company (incorporated by reference to Exhibits
           (1), (2) and (3) to the Company's Registration Statement No. 0-25642 on Form 8-A).
 
5.1        Opinion and consent of Sullivan & Cromwell.
 
23.1       Consent of Coopers & Lybrand L.L.P.
 
23.2       Consent of Ernst & Young LLP.
 
23.3       Consent of Sullivan & Cromwell (included in 5.1 above).
 
24.1       Power of Attorney.*
</TABLE>
    
 
- ------------------------
 
   
*   Previously filed.
    
 
ITEM 17. UNDERTAKINGS.
 
    The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act of 1933, each filing of the
registrant's annual report pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 (and, where applicable, each filing of an employee benefit
plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of
1934) that is incorporated by reference in the registration statement shall be
deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be
the initial BONA FIDE offering thereof.
 
    Insofar as indemnification for liabilities arising under the Securities Act
of 1933 may be permitted to directors, officers and controlling persons of the
registrant, pursuant to the foregoing provisions, or otherwise, the registrant
has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities Act
of 1933 and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or
proceeding) is asserted by any such director, officer or controlling person in
connection with the securities being registered, the registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question of whether or not
such indemnification is against public policy as expressed in the Securities Act
of 1933 and will be governed by the final adjudication of such issue.
 
                                      II-2
<PAGE>
    The undersigned registrant hereby undertakes that:
 
        (1)  For purposes of determining any liability under the Securities Act
    of 1933, the information omitted from the form of prospectus filed as part
    of this registration statement in reliance upon Rule 430A and contained in a
    form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4)
    or 497(h) under the Securities Act of 1933 shall be deemed to be part of
    this registration statement as of the time it was declared effective.
 
        (2)  For the purpose of determining any liability under the Securities
    Act of 1933, each post-effective amendment that contains a form of
    prospectus shall be deemed to be a new registration statement relating to
    the securities offered therein, and the offering of such securities at that
    time shall be deemed to be the initial BONA FIDE offering thereof.
 
                                      II-3
<PAGE>
                                   SIGNATURES
 
   
    Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this Amendment to
Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Louisville and State of Kentucky, on the 18th
day of September, 1997.
    
 
                                COMMONWEALTH INDUSTRIES, INC.
 
                                BY:             /S/ MARK V. KAMINSKI
                                     -----------------------------------------
                                                  Mark V. Kaminski
                                       PRESIDENT AND CHIEF EXECUTIVE OFFICER
 
   
    Pursuant to the requirements of the Securities Act of 1933, this Amendment
to Registration Statement has been signed by the following persons in the
capacities indicated on September 18, 1997.
    
 
          SIGNATURE                        TITLE
- ------------------------------  ---------------------------
 
              *                 Chairman of the Board
- ------------------------------
         Paul E. Lego
 
                                President, Chief Executive
     /s/ MARK V. KAMINSKI         Officer and Director
- ------------------------------    (Principal Executive
       Mark V. Kaminski           Officer)
 
                                Executive Vice President,
   /s/ DONALD L. MARSH, JR.       Chief Financial Officer
- ------------------------------    and Secretary (Principal
     Donald L. Marsh, Jr.         Financial and Accounting
                                  Officer)
 
              *                 Director
- ------------------------------
      Catherine G. Burke
 
              *                 Director
- ------------------------------
    C. Frederick Fetterolf
 
      /s/ JOHN E. MEROW         Director
- ------------------------------
        John E. Merow
 
              *                 Director
- ------------------------------
        Victor Torasso
 
<TABLE>
<S>        <C>                                   <C>
* By:            /s/ DONALD L. MARSH, JR.        Attorney-in-Fact
           -----------------------------------
                   Donald L. Marsh, Jr.
</TABLE>
 
                                      II-4

<PAGE>
                                                                    Exhibit 1.1

                                  5,000,000 Shares
     
     
                             COMMONWEALTH INDUSTRIES, INC.
     
                             Common Stock, $0.01 par value
           



                                 UNDERWRITING AGREEMENT






          __________, 19__ 

<PAGE>
                                                         _____________, 19__
     
     
     
     Morgan Stanley & Co. Incorporated
     Merrill Lynch, Pierce, Fenner & Smith Incorporated
     c/o    Morgan Stanley & Co. Incorporated
            1585 Broadway
            New York, New York 10036
     
     Dear Sirs and Mesdames:
     
     Commonwealth Industries Inc., a Delaware corporation (the "Company"), 
proposes to issue and sell to the several Underwriters named in Schedule I 
hereto (the "Underwriters"), an aggregate of 5,000,000 shares of the common 
stock, $0.01 par value, of the Company (the "Firm Shares").

     The Company also proposes to issue and sell to the several Underwriters 
not more than an additional 750,000 shares of its common stock, $0.01 par 
value (the "Additional Shares"), if and to the extent that you, as managers 
of the offering, shall have determined to exercise, on behalf of the 
Underwriters, the right to purchase such shares of common stock granted to 
the Underwriters in Section 2 hereof.  The terms "Firm Shares" and 
"Additional Shares" shall in be deemed each case to include the rights to 
purchase Participating Preferred Stock.  The Firm Shares and the Additional 
Shares are hereinafter collectively referred to as the "Shares."  The shares 
of common stock, $0.01 par value, of the Company to be outstanding after 
giving effect to the sales contemplated hereby are hereinafter referred to as 
the "Common Stock." 

     The Company has filed with the Securities and Exchange Commission (the 
"Commission") a registration statement on Form S-3 (File No. 333-32541), 
including a prospectus, relating to the Shares.  The registration statement 
as amended at the time it becomes effective, including the information (if 
any) deemed to be part of the registration statement at the time of 
effectiveness pursuant to Rule 430A under the Securities Act of 1933, as 
amended (the "Securities Act"), is hereinafter referred to as the 
"Registration Statement"; the prospectus in the form first used to confirm 
sales of Shares is hereinafter referred to as the "Prospectus" (including, in 
the case of all references to the Registration Statement or the Prospectus, 
unless the context requires otherwise, documents incorporated by reference 
therein).  If the Company has filed an abbreviated 

                                       1
<PAGE>

registration statement to register additional shares of Common Stock
pursuant to Rule 462(b) under the Securities Act (the "Rule 462 Registration
Statement"), then any reference herein to the term "Registration Statement"
shall be deemed to include such Rule 462 Registration Statement.

     1.     Representations and Warranties.  The Company represents and 
warrants to and agrees with each of the Underwriters that:

          (a)    The Registration Statement has become effective; no stop 
     order suspending the effectiveness of the Registration Statement is in 
     effect, and no proceedings for such purpose are pending before or 
     threatened by the Commission.

        (b)(i) Each document, if any, filed or to be filed pursuant to the 
     Exchange Act and incorporated by reference in the Prospectus complied or 
     will comply when so filed in all material respects with the Securities 
     Exchange Act of 1934, as amended (the "Exchange Act") and the applicable 
     rules and regulations of the Commission thereunder,(ii) the Registration 
     Statement, when it became effective, did not contain and, as amended or 
     supplemented, if applicable, will not contain any untrue statement of a 
     material fact or omit to state a material fact required to be stated 
     therein or necessary to make the statements therein, in light of the 
     circumstances under which they were made, not misleading,(iii) the 
     Registration Statement and the Prospectus comply and, as amended or 
     supplemented, if applicable, will comply in all material respects with 
     the Securities Act and the applicable rules and regulations of the 
     Commission thereunder and (iv) the Prospectus does not contain and, as 
     amended or supplemented, if applicable, will not contain any untrue 
     statement of a material fact or omit to state a material fact necessary 
     to make the statements therein, in the light of the circumstances under 
     which they were made, not misleading, except that the representations 
     and warranties set forth in this paragraph 1(b) do not apply to 
     statements or omissions in the Registration Statement or the Prospectus 
     based upon information furnished to the Company in writing by any 
     Underwriter expressly for use therein.

          (c)    The Company has been duly incorporated, is validly existing 
     as a corporation in good standing under the laws of the state of Delaware,
     has the corporate power and authority to own its property and to conduct 
     its business as described in the Prospectus, except where the failure to 
     have such power would not have a material adverse effect on the Company 
     and its subsidiaries, taken as a whole, and is duly qualified to 
     transact business and is in good standing in each jurisdiction in which 
     the conduct 

                                         2
<PAGE>

     of its business or its ownership or leasing of property 
     requires such qualification, except to the extent that the failure to be 
     so qualified or be in good standing would not have a material adverse 
     effect on the Company and its subsidiaries, taken as a whole.

          (d)    Each subsidiary of the Company has been duly incorporated, 
     is validly existing as a corporation in good standing under the laws of 
     the jurisdiction of its incorporation, has the corporate power and 
     authority to own its property and to conduct its business as described 
     in the Prospectus and is duly qualified to transact business and is in 
     good standing in each jurisdiction in which the conduct of its business 
     or its ownership or leasing of property requires such qualification, 
     except to the extent that the failure to be so qualified or be in good 
     standing would not have a material adverse effect on the Company and its 
     subsidiaries, taken as a whole; all of the issued shares of capital 
     stock of each subsidiary of the Company have been duly and validly 
     authorized and issued, are fully paid and non-assessable and are owned 
     by the Company, free and clear of all liens, encumbrances, equities or 
     claims other than the pledge to National Westminster Bank Plc, as 
     administrative agent ("NatWest"), under the Commonwealth Amended and 
     Restated Pledge and Security Agreement dated as of November 29, 1996 
     (the "Pledge Agreement").

          (e)    This Agreement has been duly authorized, executed and 
     delivered by the Company.

          (f)    The authorized capital stock of the Company is as set forth 
     in the Prospectus under the caption "Capitalization".

          (g)    The shares of Common Stock outstanding prior to the issuance 
     of the Shares have been duly authorized and validly issued, and are 
     fully paid and non-assessable.

          (h)    The Shares have been duly authorized and, when issued and 
     paid for in accordance with the terms of this Agreement, will be validly 
     issued, fully paid and non-assessable, and such Shares will not be 
     subject to any preemptive rights of any stockholder of the Company in 
     connection with the transactions contemplated by this Agreement.

          (i)    Neither the Company nor any of its subsidiaries is in 
     default in the performance or observance of any obligation, agreement, 
     covenant or condition contained in any other agreement or other 
     instrument binding upon the Company or any of its subsidiaries that is 
     material to the Company and its subsidiaries, taken as a whole, in each 
     case, except for 

                                             3
<PAGE>

     such defaults that would not have a material adverse effect on the 
     Company and its subsidiaries, taken as a whole; the execution and 
     delivery by the Company of, and the performance by the Company of its 
     obligations under, this Agreement will not (i) violate the certificate 
     of incorporation or by-laws of the Company or any of its subsidiaries, 
     (ii) result in a default under or breach of or result in the creation or 
     imposition of any lien or encumbrance on the assets or liabilities of 
     the Company or any of its subsidiaries under any agreement or other 
     instrument binding upon the Company or any of its subsidiaries that is 
     material to the Company and its subsidiaries, taken as a whole, (iii) 
     violate any law applicable to the Company or its subsidiaries, or (iv) 
     violate any judgment, order or decree of any governmental body, agency 
     or court having jurisdiction over the Company or any subsidiary, except 
     in each case, for such violations that would not have a material adverse 
     effect on the Company and its subsidiaries, taken as a whole; and no 
     consent, approval, authorization or order of, or qualification with, any 
     governmental body or agency is required for the performance by the 
     Company of its obligations under this Agreement, except such as may be 
     required by the Securities Act or the securities or Blue Sky laws of the 
     various states in connection with the offer and sale of the Shares.

          (j)    There has not occurred any material adverse change, or any 
     development involving a prospective material adverse change, in the 
     condition, financial or otherwise, or in the earnings, business or 
     operations of the Company and its subsidiaries, taken as a whole, from 
     that set forth in the Prospectus (exclusive of any amendments or 
     supplements thereto subsequent to the date of this Agreement).

          (k)    The Company and its subsidiaries each owns, possesses or has 
     obtained all material governmental licenses, permits, certificates, 
     consents, orders, approvals and other material authorizations necessary 
     to own or lease, as the case may be, and to operate its properties and 
     to carry on its business as presently conducted, and neither the Company 
     nor any of its subsidiaries has received any notice of proceedings 
     relating to revocation or modification of any such licenses, permits, 
     certificates, consents, orders, approvals or authorizations, except for 
     any revocation or modification that would not have a material adverse 
     effect on the Company and its subsidiaries, taken as a whole.

          (l)    Except as described in the Registration Statement or the 
     Prospectus, there are no legal or governmental proceedings pending or, 
     to the actual knowledge of the Company, threatened to which the Company 
     or any subsidiary is a party or to which any of the properties of the 

                                         4
<PAGE>

     Company or any subsidiary is subject, which, if adversely decided, would 
     have a material adverse effect on the Company and its subsidiaries, 
     taken as a whole, or on the power or ability of the Company to perform 
     any of its obligations under this Agreement. 

          (m)    The unaudited pro forma condensed consolidated statement of 
     operations and the related notes thereto set forth in the Registration 
     Statement and the Prospectus with respect to the Company has been 
     prepared in accordance with the applicable requirements of Rule 11-02 of 
     Regulation S-X promulgated under the Exchange Act, have been compiled on 
     the pro forma basis described therein and, in the opinion of the 
     Company, the assumptions used in the preparation thereof are reasonable 
     and the adjustments used therein are based upon good faith estimates and 
     assumptions believed by the Company to be reasonable.

          (n)    Each preliminary prospectus filed as part of the 
     registration statement on Form S-3 as originally filed or as part of any 
     amendment thereto, or filed pursuant to Rule 424 or Rule 462 under the 
     Securities Act, complied when so filed in all material respects with the 
     Securities Act and the applicable rules and regulations of the 
     Commission thereunder.

          (o)    The Company is not and, after giving effect to the offering 
     and sale of the Shares and the application of the proceeds therefrom as 
     described in the Prospectus, will not be an "investment company", within 
     the meaning of the Investment Company Act of 1940, as amended.

          (p)    Except as disclosed in the Registration Statement or the 
     Prospectus or except as would not reasonably be expected to individually 
     or in the aggregate have a material adverse effect on the financial 
     condition, stockholders' equity or results of operations of the Company 
     and its subsidiaries, taken as a whole, (i) the Company and its 
     subsidiaries are each in compliance with all applicable Environmental 
     Laws, (ii) the Company and its subsidiaries have all permits, 
     authorizations and approvals required under any applicable Environmental 
     Laws and are each in compliance with their requirements, (iii) there are 
     no pending or, to the knowledge of the Company, threatened Environmental 
     Claims against the Company or any of its subsidiaries, and (iv) there 
     are no past or present events, conditions, circumstances, activities, 
     practices, incidents, actions or plans required to be disclosed in the 
     Registration Statement or the Prospectus which could reasonably be 
     expected to materially interfere with or prevent compliance by the 
     Company or any of its subsidiaries with any Environmental Law, or which 
     could 
                                        5
<PAGE>

     reasonably be expected to give rise to any liability under any 
     Environmental Law, or which could reasonably be expected to form the 
     basis of any Environmental Claim, based on or primarily related to the 
     manufacture, processing, distribution, use, generation, treatment, 
     storage, disposal, transport, shipping or handling, or the arrangement 
     for treatment or disposal or the emission, discharge, release or 
     threatened release into the environment, of any Hazardous Substance.

          For purposes of this Agreement, the following terms shall have the 
     following meanings:  "Environmental Law" means any applicable United 
     States federal, state, local or municipal statute, law, rule, 
     regulation, ordinance, code or enforceable policy and any judicial or 
     administrative interpretation thereof including any judicial or 
     administrative order, consent decree or judgment, relating to (i) the 
     environment or (ii) any Hazardous Substance; "Environmental Claims" 
     means any and all administrative, regulatory or judicial actions, suits, 
     demands, demand letters, claims, liens, notices of noncompliance or 
     violation, investigations or proceedings relating in any way to any 
     Environmental Law; and "Hazardous Substance" means any substance 
     presently listed, defined, designated or classified as hazardous, toxic, 
     radioactive or dangerous, or otherwise regulated, under any 
     Environmental Law, whether by type or by quantity, and any substance 
     containing any such substance as a component, including, without 
     limitation, any toxic waste, pollutant, contaminant, hazardous 
     substance, toxic substance, hazardous waste, special waste, industrial 
     substance or petroleum or any derivative or by-product thereof, radon, 
     radioactive material, asbestos, asbestos-containing material, urea 
     formaldehyde foam insulation, lead or polychlorinated biphenyl to the 
     extent any such substance is presently so listed, defined, designated or 
     classified, or otherwise regulated under any Environmental Law.
     
     (q)    There are no contracts, agreements or understandings between the 
Company and any person granting such person the right to require the Company 
to file a registration statement under the Securities Act with respect to any 
securities of the Company or to require the Company to include such 
securities with the Shares registered pursuant to the Registration Statement.

     2.     Agreements to Sell and Purchase. The Company hereby agrees to 
sell to the several Underwriters, and each Underwriter, upon the basis of the 
representations and warranties herein contained, but subject to the 
conditions hereinafter stated, agrees, severally and not jointly, to purchase 
from the Company the respective numbers of Firm Shares set forth in Schedule 
I hereto opposite its name at $______ a share (the "Purchase Price").

                                             6
<PAGE>

     On the basis of the representations and warranties contained in this 
Agreement, and subject to its terms and conditions, the Company agrees to 
sell to the Underwriters the Additional Shares, and the Underwriters shall 
have a one-time right to purchase, severally and not jointly, up to 750,000 
Additional Shares at the Purchase Price.  If you, on behalf of the 
Underwriters, elect to exercise such option, you shall so notify the Company 
in writing not later than 30 days after the date of this Agreement, which 
notice shall specify the number of Additional Shares to be purchased by the 
Underwriters and the date on which such shares are to be purchased.  Such 
date may be the same as the Closing Date (as defined below) but not earlier 
than the Closing Date nor earlier than three business days or later than ten 
business days after the date of such notice. Additional Shares may be 
purchased as provided in Section 4 hereof solely for the purpose of covering 
over-allotments made in connection with the offering of the Firm Shares.  If 
any Additional Shares are to be purchased, each Underwriter agrees, severally 
and not jointly, to purchase the number of Additional Shares (subject to such 
adjustments to eliminate fractional shares as you may determine) that bears 
the same proportion to the total number of Additional Shares to be purchased 
as the number of Firm Shares set forth in Schedule I hereto opposite the name 
of such Underwriter bears to the total number of Firm Shares.

     The Company hereby agrees that, without the prior written consent of 
Morgan Stanley & Co. Incorporated on behalf of the Underwriters, it will not, 
during the period ending 90 days after the date of the Prospectus, (i) offer, 
pledge, sell, contract to sell, sell any option or contract to purchase, 
purchase any option or contract to sell, grant any option, right or warrant 
to purchase, or otherwise transfer or dispose of, directly or indirectly, any 
shares of Common Stock or any securities convertible into or exercisable or 
exchangeable for Common Stock or (ii) enter into any swap or other 
arrangement that transfers to another, in whole or in part, any of the 
economic consequences of ownership of the Common Stock, whether any such 
transaction described in clause (i) or (ii) above is to be settled by 
delivery of Common Stock or such other securities, in cash or otherwise.  The 
foregoing sentence shall not apply to (A) the Shares to be sold hereunder, 
(B) the issuance by the Company of options under its benefit plans existing 
on the date hereof or (C) the issuance by the Company of shares of Common 
Stock upon the exercise of an option or warrant or the conversion of a 
security outstanding on the date hereof of which the Underwriters have been 
advised in writing.

     3.     Terms of Public Offering. The Company is advised by you that the 
Underwriters propose to make a public offering of their respective portions 
of the Shares as soon after the Registration Statement and this Agreement 
have become effective as in your judgment is advisable.  The Company is 
further advised by you that the Shares are to be offered to the public 
initially at $___ a share (the "Public Offering Price") and to certain 
dealers selected by you at a price that 

                                        7
<PAGE>

represents a concession not in excess of $____ a share under the Public 
Offering Price, and that any Underwriter may allow, and such dealers may 
reallow, a concession, not in excess of $___ a share, to any Underwriter or 
to certain other dealers.

     4.     Payment and Delivery. Payment for the Firm Shares shall be made 
by wire transfer of Federal or other funds immediately available in New York 
City against delivery of such Firm Shares for the respective accounts of the 
several Underwriters at 10:00 a.m., New York City time, on ____________, 
19__, or at such other time on the same or such other date, not later than 
_________, 19__, as shall be designated in writing by you.  The time and date 
of such payment are hereinafter referred to as the "Closing Date."

     Payment for any Additional Shares shall be made to the Company by wire 
transfer of Federal or other funds immediately available in New York City 
against delivery of such Additional Shares for the respective accounts of the 
several Underwriters at the offices of Sullivan & Cromwell, 125 Broad Street, 
New York, New York 10004 at 10:00 a.m., New York City time, on the date 
specified in the notice described in Section 2 or at such other time on the 
same or on such other date, in any event not later than _______, 19__, as 
shall be designated in writing by you.  The time and date of such payment are 
hereinafter referred to as the "Option Closing Date."

     Certificates for the Firm Shares and Additional Shares shall be in 
definitive form and registered in such names and in such denominations as you 
shall request in writing not later than one full business day prior to the 
Closing Date or the Option Closing Date, as the case may be.  The 
certificates evidencing the Firm Shares and Additional Shares shall be 
delivered to you on the Closing Date or the Option Closing Date, as the case 
may be, for the respective accounts of the several Underwriters, with any 
transfer taxes payable in connection with the transfer of the Shares to the 
Underwriters duly paid, against payment of the Purchase Price therefor.

     5.     Conditions to the Underwriters' Obligations. The obligations of 
the Company to sell the Shares to the Underwriters and the several 
obligations of the Underwriters to purchase and pay for the Shares on the 
Closing Date are subject to the condition that the Registration Statement 
shall have become effective on the date hereof.

     The several obligations of the Underwriters are subject to the following 
further conditions:

                                             8
<PAGE>

     (a)    Subsequent to the execution and delivery of this Agreement and 
prior to the Closing Date:

          (i)    there shall not have occurred any downgrading, nor shall any 
     notice have been given of any intended or potential downgrading or of 
     any review for a possible change that does not indicate the direction of 
     the possible change, in the rating accorded any of the Company's 
     securities by any "nationally recognized statistical rating 
     organization," as such term is defined for purposes of Rule 436(g)(2) 
     under the Securities Act; and

          (ii)   there shall not have occurred any change, or any development 
     involving a prospective change, in the condition, financial or 
     otherwise, or in the earnings, business or operations of the Company and 
     its subsidiaries, taken as a whole, from that set forth in the 
     Prospectus (exclusive of any amendments or supplements thereto 
     subsequent to the date of this Agreement) that, in your judgment, is 
     material and adverse and that makes it, in your judgment, impracticable 
     to market the Shares on the terms and in the manner contemplated in the 
     Prospectus.

     (b)    The Underwriters shall have received on the Closing Date a 
certificate, dated the Closing Date and signed by an executive officer of the 
Company, to the effect set forth in Section 5(a)(i) above and to the effect that
the representations and warranties of the Company contained in this Agreement 
are true and correct as of the Closing Date and that the Company has complied in
all material respects with all of the agreements and satisfied all of the 
conditions in all material respects on its part to be performed or satisfied 
hereunder on or before the Closing Date.

          The officer signing and delivering such certificate may rely upon 
     the best of his or her knowledge as to proceedings threatened.

          (c)    The Underwriters shall have received on the Closing Date an 
     opinion of Sullivan & Cromwell, counsel for the Company, dated the 
     Closing Date, to the effect that:

              (i)    Each of the Company, Commonwealth Aluminum Corporation, 
         CI Holdings, Inc., Commonwealth Aluminum Sales Corporation and 
         Alflex Corporation has been duly incorporated and is an existing 
         corporation in good standing under the laws of the State of Delaware;

                                              9
<PAGE>


              (ii)   Each of Commonwealth Aluminum Corporation and Alflex 
         Corporation has the corporate power and authority under the laws of 
         the State of Delaware to own, lease and operate its properties and 
         conduct its business as described in the Registration Statement and 
         the Prospectus;

              (iii)  Commonwealth Aluminum Corporation is duly qualified to 
         transact business as a foreign corporation and is in good standing 
         in the Commonwealth of Kentucky;

              (iv)   Commonwealth Aluminum Sales Corporation is duly 
         qualified to transact business as a foreign corporation and is in 
         good standing in the Commonwealth of Kentucky and the States of 
         Illinois and California;

              (v)    the authorized capital stock of the Company is as set 
         forth in the Prospectus under the caption "Capitalization";

              (vi)   the shares of Common Stock outstanding prior to the 
         issuance of the Shares have been duly authorized and are validly 
         issued, fully paid and non-assessable;

              (vii)  all of the issued shares of capital stock of each 
         subsidiary of the Company have been duly authorized and validly 
         issued, are fully paid and non-assessable and are owned by the 
         Company, free and clear of all liens, encumbrances, equities or 
         claims other than the pledge to NatWest under the Pledge Agreement;

              (viii) the Shares have been duly authorized and, when issued 
         and paid for in accordance with the terms of this Agreement, will be 
         validly issued, fully paid and non-assessable, and such Shares will 
         not be issued in violation of the preemptive rights of any 
         stockholder of the Company;

              (ix)   this Agreement has been duly authorized, executed and 
         delivered by the Company;

              (x)    the execution and delivery by the Company of, and the 
         performance by the Company of its obligations under, this Agreement 
         will not (i) violate the certificate of incorporation or by-laws of 
         the Company, (ii) result in a default under or breach of or result 
         in the creation or imposition of any lien or encumbrance 

                                           10
<PAGE>
         
         upon any property or assets of the Company under the agreements 
         listed in Part IV, Item 14(c), Exhibit Numbers 3.3 and 10.1 through 
         10.7 of the Company's Annual Report on Form 10-K for the year ended 
         December 31, 1996, (iii) violate any judgment, order or decree of 
         any government, governmental instrumentality or court having 
         jurisdiction over the Company or any of its properties, known to 
         such counsel, or (iv) violate any Federal law of the United States 
         or law of the State of New York applicable to the Company or the 
         Delaware General Corporation Law; provided, however, that for the 
         purposes of this paragraph (x), such counsel need express no opinion 
         with respect to Federal or state securities laws or other antifraud 
         laws; provided, further, that insofar as performance by the Company 
         of its obligations under this Agreement is concerned, such counsel 
         need express no opinion as to bankruptcy, insolvency, 
         reorganization, moratorium and similar laws of general applicability 
         relating to or affecting creditors' rights;

              (xi)   the Company is not and, after giving effect to the 
         offering and sale of the Shares and the application of the proceeds 
         thereof as described in the Prospectus, will not be an "investment 
         company", within the meaning of the Investment Company Act of 1940, 
         as amended;

     Such counsel shall also furnish you with a letter to the effect that:  
as counsel to the Company, they reviewed the Registration Statement and the 
Prospectus, participated in discussions with representatives of the 
Underwriters and of the Company and its accountants and advised the Company 
as to the requirements of the Securities Act and the applicable rules and 
regulations thereunder; between the effectiveness of the Registration 
Statement and the Closing Time, such counsel participated in further 
discussions with representatives of the Underwriters and of the Company and 
its accountants, in which the contents of certain portions of the Prospectus 
and related matters were discussed, and reviewed certain documents filed by 
the Company with the Commission, certificates of certain officers of the 
Company and a letter from the Company's independent accountants; on the basis 
of the information that such counsel gained in the course of the performance 
of the services referred to above, considered in the light of such counsel's 
understanding of the applicable law (including the requirements of Form S-3 
and the character of the prospectus contemplated thereby) and the experience 
such counsel have gained through their practice under the Securities Act, 
they confirm to you that, in such counsel's opinion, the Registration 
Statement and the Prospectus, as of the effective date of the Registration 
Statement, appeared on their face to be appropriately responsive 

                                    11
<PAGE>

in all material respects to the requirements of the Securities Act and the 
applicable rules and regulations of the Commission thereunder; further, 
nothing that came to such counsel's attention in the course of such review 
has caused such counsel to believe that the Registration Statement or the 
Prospectus, as of such effective date, contained any untrue statement of a 
material fact or omitted to state any material fact required to be stated 
therein or necessary to make the statements therein not misleading; also, 
nothing that has come to such counsel's attention in the course of the 
procedures described in the second clause of this paragraph has caused such 
counsel to believe that the Prospectus, as of the Closing Time, contained any 
untrue statement of a material fact or omitted to state any material fact 
necessary in order to make the statements therein, in the light of the 
circumstances under which they were made, not misleading; in addition, such 
counsel do not know of any litigation or any governmental proceeding 
instituted or threatened against the Company that would be required to be 
disclosed in the Prospectus and is not so disclosed; also, such counsel do 
not know of any documents that are required to be filed as exhibits to the 
Registration Statement and are not so filed or of any documents that are 
required to be summarized in the Prospectus and are not so summarized; such 
counsel shall state that the limitations inherent in the independent 
verification of factual matters and the character of determinations involved 
in the registration process are such that such counsel does not assume any 
responsibility for the accuracy, completeness or fairness of the statements 
contained in the Registration Statement or the Prospectus except for those 
made under the captions "Description of Capital Stock" and "Underwriters" in 
the Prospectus insofar as they relate to provisions of documents therein 
described; also, such counsel need express no opinion or belief as to the 
financial statements or other financial or statistical data contained in the 
Registration Statement or the Prospectus.

          (d)    The Underwriters shall have received on the Closing Date an 
     opinion of Davis Polk & Wardwell, counsel for the Underwriters, dated 
     the Closing Date, covering the matters referred to in Sections 
     5(c)(viii), 5(c)(ix), and the final paragraph of Section 5(c) above.

          With respect to the final paragraph of Section 5(c) above, Davis 
     Polk & Wardwell may state that their opinion and belief are based upon 
     their participation in the preparation of the Registration Statement and 
     Prospectus and any amendments or supplements thereto (other than the 
     documents incorporated by reference) and review and discussion of the 
     contents thereof (including the documents incorporated therein by 
     reference), but are without independent check or verification, except as 
     specified. 

                                               12
<PAGE>

          (e)    The Underwriters shall have received, on each of the date 
     hereof and the Closing Date, a letter dated the date hereof or the 
     Closing Date, as the case may be, in form and substance satisfactory to 
     the Underwriters, from (i) Coopers & Lybrand LLP, independent 
     accountants for the Company, and (ii) Ernst & Young LLP, independent 
     accountants for CasTech Aluminum Group Inc. as of the date of their 
     opinion with respect to the financial statements of CasTech Aluminum 
     Group Inc. for the fiscal year ended March 31, 1996, each containing 
     statements and information of the type ordinarily included in 
     accountants' "comfort letters" to underwriters with respect to the 
     financial statements and certain financial information contained in or 
     incorporated by reference into the Registration Statement and the 
     Prospectus; provided that the letter delivered on the Closing Date shall 
     use a "cut-off date" not earlier than the date hereof.

          (f)    The "lock-up" agreements, each substantially in the form of 
     Exhibit A hereto, between you and certain executive officers and 
     directors of the Company relating to sales and certain other 
     dispositions of shares of Common Stock or certain other securities, 
     delivered to you on or before the date hereof, shall be in full force 
     and effect on the Closing Date.

     The several obligations of the Underwriters to purchase Additional Shares
hereunder are subject to the delivery to you on the Option Closing Date of such
documents as you may reasonably request with respect to the good standing of the
Company, the due authorization and issuance of the Additional Shares and other
matters related to the issuance of the Additional Shares as shall be reasonably
requested by the Underwriters.

     6.     Covenants of the Company. In further consideration of the agreements
of the Underwriters herein contained, the Company covenants with each 
Underwriter as follows:

          (a)    To furnish to you, without charge, a conformed copy of the 
     Registration Statement (including exhibits thereto and documents 
     incorporated therein by reference) and for delivery to each other 
     Underwriter a conformed copy of the Registration Statement (without 
     exhibits thereto but including documents incorporated therein by 
     reference) and to furnish to you in New York City, without charge, on 
     the business day next succeeding the date of this Agreement and during 
     the period mentioned in Section 6(c) below, as many copies of the 
     Prospectus and any supplements and amendments thereto or to the 
     Registration Statement as you may reasonably request. The terms 
     "supplement" and "amendment" or "amend" as used in this Agreement shall 
     include all 

                                        13
<PAGE>

     documents subsequently filed by the Company with the Commission pursuant 
     to the Exchange Act that are deemed to be incorporated by reference in 
     the Prospectus.

          (b)    Before amending or supplementing the Registration Statement 
     or the Prospectus, to furnish to you a copy of each such proposed 
     amendment or supplement and not to file any such proposed amendment or 
     supplement to which you reasonably object, and to file with the 
     Commission within the applicable period specified in Rule 424(b) under 
     the Securities Act any prospectus required to be filed pursuant to such 
     Rule.

          (c)    If, during such period after the first date of the public 
     offering of the Shares as in the opinion of counsel for the Underwriters 
     the Prospectus is required by law to be delivered in connection with 
     sales by an Underwriter or dealer, any event shall occur or condition 
     exist as a result of which it is necessary to amend or supplement the 
     Prospectus in order to make the statements therein, in the light of the 
     circumstances when the Prospectus is delivered to a purchaser, not 
     misleading, or if, in the opinion of counsel for the Underwriters, it is 
     necessary to amend or supplement the Prospectus to comply with 
     applicable law, forthwith to prepare, file with the Commission and 
     furnish, at its own expense, to the Underwriters and to the dealers 
     (whose names and addresses you will furnish to the Company) to which 
     Shares may have been sold by you on behalf of the Underwriters and to 
     any other dealers upon request, either amendments or supplements to the 
     Prospectus so that the statements in the Prospectus as so amended or 
     supplemented will not, in the light of the circumstances when the 
     Prospectus is delivered to a purchaser, be misleading or so that the 
     Prospectus, as amended or supplemented, will comply with law.

          (d)    To make generally available to the Company's security 
     holders and to you as soon as practicable an earning statement covering 
     the twelve-month period ending September 30, 1998, that satisfies the 
     provisions of Section 11(a) of the Securities Act and the rules and 
     regulations of the Commission thereunder.

          (e)    Whether or not the transactions contemplated in this 
     Agreement are consummated or this Agreement is terminated, to pay or 
     cause to be paid all expenses incident to the performance of its 
     obligations under this Agreement, including:(i) the fees, disbursements 
     and expenses of the Company's counsel and the Company's accountants in 
     connection with the registration and delivery of the Shares under the 
     Securities Act 

                                              14
<PAGE>

     and all other fees or expenses in connection with the preparation and 
     filing of the Registration Statement, any preliminary prospectus, the 
     Prospectus and amendments and supplements to any of the foregoing, 
     including all printing costs associated therewith, and the mailing and 
     delivering of copies thereof to the Underwriters and dealers, in such 
     quantities as may be reasonably requested by the Underwriters, (ii)all 
     costs and expenses related to the transfer and delivery of the Shares to 
     the Underwriters, including any transfer or other taxes payable upon the 
     transfer to the Underwriters,(iii) the cost of printing or producing any 
     Blue Sky memorandum in connection with the offer and sale of the Shares 
     under state securities laws, including the reasonable fees and 
     disbursements of counsel for the Underwriters in connection with the 
     Blue Sky memorandum,(iv) all filing fees and the reasonable fees and 
     disbursements of counsel to the Underwriters incurred in connection with 
     the review and qualification of the offering of the Shares by the 
     National Association of Securities Dealers, Inc., (v)all costs and 
     expenses incident to listing the Shares on the Nasdaq National 
     Market,(vi) the cost of printing certificates representing the 
     Shares,(vii) the costs and charges of any transfer agent, registrar or 
     depositary,(viii) the costs and expenses of the Company relating to 
     investor presentations on any "road show" undertaken in connection with 
     the marketing of the offering of the Shares, including, without 
     limitation, expenses associated with the production of road show slides 
     and graphics, fees and expenses of any consultants engaged in connection 
     with the road show presentations with the prior approval of the Company, 
     travel and lodging expenses of the representatives and officers of the 
     Company and any such consultants, and 50% of the cost of any aircraft 
     chartered in connection with the road show, and (ix) all other costs and 
     expenses incident to the performance of the obligations of the Company 
     hereunder for which provision is not otherwise made in this Section. It 
     is understood, however, that except as provided in this Section, Section 7 
     entitled "Indemnity and Contribution", and the last paragraph of Section 9 
     below, the Underwriters will pay all of their costs and expenses, including
     fees  and disbursements of their counsel, stock transfer taxes payable on 
     resale of any of the Shares by them, travel and lodging expenses of the 
     representatives of the Underwriters and any advertising expenses 
     connected with any offers they may make.

     7.     Indemnity and Contribution.(a) The Company agrees to indemnify 
and hold harmless each Underwriter and each person, if any, who controls any 
Underwriter within the meaning of either Section 15 of the Securities Act or 
Section 20 of the Exchange Act, from and against any and all losses, claims, 
damages and liabilities (including, without limitation, any legal or other 
expenses

                                          15

<PAGE>

reasonably incurred in connection with defending or investigating any such 
action or claim) caused by any untrue statement or alleged untrue statement 
of a material fact contained in the Registration Statement or any amendment 
thereof, any preliminary prospectus or the Prospectus (as amended or 
supplemented if the Company shall have furnished any amendments or 
supplements thereto), or caused by any omission or alleged omission to state 
therein a material fact required to be stated therein or necessary to make 
the statements therein not misleading, except insofar as such losses, claims, 
damages or liabilities are caused by any such untrue statement or omission or 
alleged untrue statement or omission based upon information furnished to the 
Company in writing by any Underwriter expressly for use therein provided, 
however, the foregoing indemnity with respect to any untrue statement or 
omission or alleged untrue statement or omission made in any preliminary 
prospectus shall not inure to the benefit of any Underwriter (or any person 
controlling such Underwriter) from whom the person asserting any such losses, 
claims, damages and liabilities purchased any of the Shares that are the 
subject thereof if such person was not sent or given a copy of the Prospectus 
(or the Prospectus as amended or supplemented), at or prior to the written 
confirmation of the sale of such Shares to such person and the untrue 
statement or omission or alleged untrue statement or omission made in such 
preliminary prospectus was corrected in the Prospectus (or the Prospectus as 
amended or supplemented).

     (b)    Each Underwriter agrees, severally and not jointly, to indemnify 
and hold harmless the Company, its directors, its officers who sign the 
Registration Statement and each person, if any, who controls the Company 
within the meaning of either Section 15 of the Securities Act or Section 20 
of the Exchange Act to the same extent as the foregoing indemnity from the 
Company to such Underwriter, but only with reference to information furnished 
to the Company in writing by such Underwriter expressly for use in the 
Registration Statement, any preliminary prospectus, the Prospectus or any 
amendments or supplements thereto.

     (c)    In case any proceeding (including any governmental investigation) 
shall be instituted involving any person in respect of which indemnity may be 
sought pursuant to Section 7(a) or 7(b), such person (the "indemnified 
party") shall promptly notify the person against whom such indemnity may be 
sought (the "indemnifying party") in writing and the indemnifying party, upon 
request of the indemnified party, shall retain counsel reasonably 
satisfactory to the indemnified party to represent the indemnified party and 
any others the indemnifying party may designate in such proceeding and shall 
pay the reasonable fees and disbursements of such counsel related to such 
proceeding. In any such proceeding, any indemnified party shall have the 
right to retain its own counsel, but the fees and expenses of such counsel 
shall be at the expense of such indemnified party unless (i) the indemnifying 
party and the indemnified party shall have mutually 

                                         16

<PAGE>

agreed to the retention of such counsel or (ii) the named parties to any such 
proceeding (including any impleaded parties) include both the indemnifying 
party and the indemnified party and representation of both parties by the 
same counsel would be inappropriate due to actual or potential differing 
interests between them. It is understood that the indemnifying party shall 
not, in respect of the legal expenses of any indemnified party in connection 
with any proceeding or related proceedings in the same jurisdiction, be 
liable for the fees and expenses of more than one separate firm (in addition 
to any local counsel) for all such indemnified parties and that all such fees 
and expenses shall be reimbursed as they are incurred. Such firm shall be 
designated in writing by Morgan Stanley & Co. Incorporated, in the case of 
parties indemnified pursuant to Section 7(a), and by the Company, in the case 
of parties indemnified pursuant to Section 7(b). The indemnifying party shall 
not be liable for any settlement of any proceeding effected without its 
written consent, but if settled with such consent or if there be a final 
judgment for the plaintiff, the indemnifying party agrees to indemnify the 
indemnified party from and against any loss or liability by reason of such 
settlement or judgment. No indemnifying party shall, without the prior 
written consent of the indemnified party, effect any settlement of any 
pending or threatened proceeding in respect of which any indemnified party is 
or could have been a party and indemnity could have been sought hereunder by 
such indemnified party, unless such settlement includes an unconditional 
release of such indemnified party from all liability on claims that are the 
subject matter of such proceeding.

     (d)    To the extent the indemnification provided for in Section 7(a) or 
7(b) is unavailable to an indemnified party or insufficient in respect of any 
losses, claims, damages or liabilities referred to therein, then each 
indemnifying party under such paragraph, in lieu of indemnifying such 
indemnified party thereunder, shall contribute to the amount paid or payable 
by such indemnified party as a result of such losses, claims, damages or 
liabilities (i) in such proportion as is appropriate to reflect the relative 
benefits received by the Company on the one hand and the Underwriters on the 
other hand from the offering of the Shares or (ii) if the allocation provided 
by clause 7(d)(i) above is not permitted by applicable law, in such 
proportion as is appropriate to reflect not only the relative benefits 
referred to in clause 7(d)(i) above but also the relative fault of the 
Company on the one hand and of the Underwriters on the other hand in 
connection with the statements or omissions that resulted in such losses, 
claims, damages or liabilities, as well as any other relevant equitable 
considerations. The relative benefits received by the Company on the one hand 
and the Underwriters on the other hand in connection with the offering of the 
Shares shall be deemed to be in the same respective proportions as the net 
proceeds from the offering of the Shares (before deducting expenses) received 
by the Company and the total underwriting discounts and commissions received 
by the Underwriters, in each case as set forth 

                                       17
<PAGE>

in the table on the cover of the Prospectus, bear to the aggregate Public 
Offering Price of the Shares. The relative fault of the Company on the one 
hand and the Underwriters on the other hand shall be determined by reference 
to, among other things, whether the untrue or alleged untrue statement of a 
material fact or the omission or alleged omission to state a material fact 
relates to information supplied by the Company or by the Underwriters and the 
parties' relative intent, knowledge, access to information and opportunity to 
correct or prevent such statement or omission. The Underwriters' respective 
obligations to contribute pursuant to this Section 7 are several in 
proportion to the respective number of Shares they have purchased hereunder, 
and not joint.

     (e)    The Company and the Underwriters agree that it would not be just 
or equitable if contribution pursuant to this Section 7 were determined by 
pro rata allocation (even if the Underwriters were treated as one entity for 
such purpose) or by any other method of allocation that does not take account 
of the equitable considerations referred to in Section 7(d). The amount paid 
or payable by an indemnified party as a result of the losses, claims, damages 
and liabilities referred to in the immediately preceding paragraph shall be 
deemed to include, subject to the limitations set forth above, any legal or 
other expenses reasonably incurred by such indemnified party in connection 
with investigating or defending any such action or claim. Notwithstanding the 
provisions of this Section 7, no Underwriter shall be required to contribute 
any amount in excess of the amount by which the total price at which the 
Shares underwritten by it and distributed to the public were offered to the 
public exceeds the amount of any damages that such Underwriter has otherwise 
been required to pay by reason of such untrue or alleged untrue statement or 
omission or alleged omission. No person guilty of fraudulent 
misrepresentation (within the meaning of Section 11(f) of the Securities Act) 
shall be entitled to contribution from any person who was not guilty of such 
fraudulent misrepresentation. The remedies provided for in this Section 7 are 
not exclusive and shall not limit any rights or remedies which may otherwise 
be available to any indemnified party at law or in equity.

     (f)    The indemnity and contribution provisions contained in this 
Section 7 and the representations, warranties and other statements of the 
Company contained in this Agreement shall remain operative and in full force 
and effect regardless of (i) any termination of this Agreement,(ii) any 
investigation made by or on behalf of any Underwriter or any person 
controlling any Underwriter or by or on behalf of the Company, its officers 
or directors or any person controlling the Company and (iii) acceptance of 
and payment for any of the Shares.

     8.     Termination. This Agreement shall be subject to termination by 
notice given by you to the Company, if (a) after the execution and delivery 
of this Agreement and prior to the Closing Date (i) trading generally shall 
have been 

                                            18
<PAGE>

suspended or materially limited on or by, as the case may be, any of the New 
York Stock Exchange, the American Stock Exchange or the National Association 
of Securities Dealers, Inc.,(ii) trading of any securities of the Company 
shall have been suspended on any exchange or in any over-the-counter 
market,(iii) a general moratorium on commercial banking activities in New 
York shall have been declared by either Federal or New York State authorities 
or (iv) there shall have occurred any outbreak or escalation of hostilities 
or any change in financial markets or any calamity or crisis that, in your 
judgment, is material and adverse and (b) in the case of any of the events 
specified in clauses 8(a)(i) through 8(a)(iv), such event, singly or together 
with any other such event, makes it, in your judgment, impracticable to 
market the Shares on the terms and in the manner contemplated in the 
Prospectus.

     9.     Effectiveness; Defaulting Underwriters. This Agreement shall 
become effective upon the execution and delivery hereof by the parties hereto.

     If, on the Closing Date or the Option Closing Date, as the case may be, 
any one or more of the Underwriters shall fail or refuse to purchase Shares 
that it has or they have agreed to purchase hereunder on such date, and the 
aggregate number of Shares which such defaulting Underwriter or Underwriters 
agreed but failed or refused to purchase is not more than one-tenth of the 
aggregate number of the Shares to be purchased on such date, the other 
Underwriters shall be obligated severally in the proportions that the number 
of Firm Shares set forth opposite their respective names in Schedule I bears 
to the aggregate number of Firm Shares set forth opposite the names of all 
such non-defaulting Underwriters, or in such other proportions as you may 
specify, to purchase the Shares which such defaulting Underwriter or 
Underwriters agreed but failed or refused to purchase on such date; provided 
that in no event shall the number of Shares that any Underwriter has agreed 
to purchase pursuant to this Agreement be increased pursuant to this Section 
9 by an amount in excess of one-ninth of such number of Shares without the 
written consent of such Underwriter. If, on the Closing Date, any Underwriter 
or Underwriters shall fail or refuse to purchase Firm Shares and the 
aggregate number of Firm Shares with respect to which such default occurs is 
more than one-tenth of the aggregate number of Firm Shares to be purchased, 
and arrangements satisfactory to you and the Company for the purchase of such 
Firm Shares are not made within 36 hours after such default, this Agreement 
shall terminate without liability on the part of any non-defaulting 
Underwriter or the Company. In any such case either you or the Company shall 
have the right to postpone the Closing Date, but in no event for longer than 
seven days, in order that the required changes, if any, in the Registration 
Statement and in the Prospectus or in any other documents or arrangements may 
be effected. If, on the Option Closing Date, any Underwriter or Underwriters 
shall fail or refuse to purchase Additional Shares and the aggregate number 
of Additional Shares with 

                                      19
<PAGE>

respect to which such default occurs is more than one-tenth of the aggregate 
number of Additional Shares to be purchased, the non-defaulting Underwriters 
shall have the option to (i) terminate their obligation hereunder to purchase 
Additional Shares or (ii) purchase not less than the number of Additional 
Shares that such non-defaulting Underwriters would have been obligated to 
purchase in the absence of such default. Any action taken under this 
paragraph shall not relieve any defaulting Underwriter from liability in 
respect of any default of such Underwriter under this Agreement.

     If this Agreement shall be terminated by the Underwriters, or any of 
them, because of any failure or refusal on the part of the Company to comply 
with the terms or to fulfill any of the conditions of this Agreement, the 
Company will reimburse the Underwriters or such Underwriters as have so 
terminated this Agreement with respect to themselves, severally, for all 
out-of-pocket expenses (including the fees and disbursements of their 
counsel) reasonably incurred by such Underwriters in connection with this 
Agreement or the offering contemplated hereunder.

     10.    Counterparts. This Agreement may be signed in two or more 
counterparts, each of which shall be an original, with the same effect as if 
the signatures thereto and hereto were upon the same instrument.

     11.    Applicable Law. This Agreement shall be governed by and construed 
in accordance with the internal laws of the State of New York.

     12.    Headings. The headings of the sections of this Agreement have 
been inserted for convenience of reference only and shall not be deemed a 
part of this Agreement.

                                       20

<PAGE>

                                         Very truly yours,
     
                                         Commonwealth Industries, Inc.
                                        
                                        
                                        
                                         By:___________________________________
                                             Name:
                                             Title:
     
       
     
     Accepted as of the date hereof
     
     Morgan Stanley & Co. Incorporated
     Merrill Lynch, Pierce, Fenner & Smith     
                   Incorporated
     
     Acting severally on behalf of themselves
     and the several Underwriters named in 
     Schedule I hereto.
     
     By: Morgan Stanley & Co. Incorporated
     
     
     
     By:___________________________________
                 Name:
                 Title:

<PAGE>
                                                                      SCHEDULE I
     
     
     
                                                           Number of Firm Shares
               Underwriter                                     To Be Purchased
- --------------------------------------------               ---------------------


     Morgan Stanley & Co. Incorporated
     
     Merrill Lynch, Pierce, Fenner & Smith 
       Incorporated
     
     






                                                           ---------------------
          Total: ......................................
                                                           ---------------------
                                                           ---------------------
      
<PAGE>
           
                                                                       EXHIBIT A
     
     
                                    [FORM OF LOCK-UP LETTER]
     
     
                                                 ____________, 199_
     
     Morgan Stanley & Co. Incorporated
     1585 Broadway
     New York, NY 10036
     
     Dear Sirs and Mesdames:
     
             The undersigned understands that Morgan Stanley & Co. 
     Incorporated ("Morgan Stanley") proposes to enter into an Underwriting 
     Agreement (the "Underwriting Agreement") with Commonwealth Industries, 
     Inc., a Delaware corporation (the "Company"), providing for the public 
     offering (the "Public Offering") by the several Underwriters, including 
     Morgan Stanley (the "Underwriters"), of 5,000,000 shares (the "Shares") 
     of the Common Stock, $0.01  par value of the Company (the "Common 
     Stock").

             To induce the Underwriters that may participate in the Public 
     Offering to continue their efforts in connection with the Public 
     Offering, the undersigned hereby agrees that, without the prior written 
     consent of Morgan Stanley on behalf of the Underwriters, it will not, 
     during the period commencing on the date hereof and ending 90 days after 
     the date of the final prospectus relating to the Public Offering (the 
     "Prospectus"), (1) offer, pledge, sell, contract to sell, sell any 
     option or contract to purchase, purchase any option or contract to sell, 
     grant any option, right or warrant to purchase, or otherwise transfer or 
     dispose of, directly or indirectly, any shares of Common Stock or any 
     securities convertible into or exercisable or exchangeable for Common 
     Stock, or (2) enter into any swap or other arrangement that transfers to 
     another, in whole or in part, any of the economic consequences of 
     ownership of the Common Stock, whether any such transaction described in 
     clause (1) or (2) above is to be settled by delivery of Common Stock or 
     such other securities, in cash or otherwise.  The foregoing sentence 
     shall not apply to the exercise of options or warrants or the conversion 
     of a security outstanding on the date hereof; provided that any Common 
     Stock issued in connection therewith is subject to the foregoing.

<PAGE>
     
             The prior written consents of Morgan Stanley described in this 
     letter shall not be required unless and until the Underwriting Agreement 
     has been executed by Morgan Stanley and the Company. 
     
                     
                                             Very truly yours,

                                             ----------------------------------
                                             (Name)

                                             ----------------------------------
                                             (Address)
     
     
                                           2

<PAGE>
                                                                     EXHIBIT 5.1
 
                       [LETTERHEAD OF SULLIVAN CROMWELL]
 
                                                              September 18, 1997
 
Commonwealth Industries, Inc.,
500 West Jefferson Street,
Louisville, Kentucky 40202-2833
 
Dear Sirs:
 
    In connection with the registration under the Securities Act of 1933 (the
'Act') of 5,750,000 shares (the 'Securities') of Common Stock, par value $.01
share, of Commonwealth Industries, Inc., a Delaware corporation (the 'Company'),
and related stock purchase rights (the 'Rights') to be issued pursuant to the
Stockholder Protection Rights Agreement, dated as of March 6, 1996 (the 'Rights
Agreement'), between the Company and National City Bank, as Rights Agent (the
'Rights Agent'), we, as your counsel, have examined such corporate records,
certificates and other documents, and such questions of law, as we have
considered necessary or appropriate for the purposes of this opinion. Upon the
basis of such examination, we advise you that, in our opinion,
 
        (1) When the registration statement relating to the Securities and the
    Rights (the 'Registration Statement') has become effective under the Act,
    the terms of the sale of the Securities have been duly established in
    conformity with the Company's certificate of incorporation, and the
    Securities have been duly issued and sold as contemplated by the
    Registration Statement, the Securities will be validly issued, fully paid
    and nonassessable.
 
        (2) Assuming that the Rights Agreement has been duly authorized,
    executed and delivered by the Rights Agent, then when the Registration
    Statement has become effective under the Act and the Securities have been
    validly issued and sold as contemplated by the Registration Statement, the
    Rights attributable to the Securities will be validly issued.
 
    In connection with our opinion set forth in paragraph (2) above, we note
that the question whether the Board of Directors of the Company might be
required to redeem the Rights at some future time will depend upon the facts and
circumstances existing at the time and, accordingly, is beyond the scope of such
opinion.
 
    The foregoing opinion is limited to the Federal laws of the United States
and the General Corporation Law of the State of Delaware, and we are expressing
no opinion as to the effect of the laws of any other jurisdiction.
 
    We have relied as to certain matters on information obtained from public
officials, officers of the Company and other sources believed by us to be
responsible.
 
    We hereby consent to the filing of this opinion as an exhibit to the
Registration Statement and to the reference to us under the heading "Validity of
Shares" in the Prospectus. We also consent to the incorporation by reference of
this opinion into a registration statement relating to the same class of
securities covered by the Registration Statement that is filed with respect to
the same offering pursuant to Rule 462(b) under the Act. In giving such
consents, we do not thereby admit that we are in the category of persons whose
consent is required under Section 7 of the Act.
 
                                          Very truly yours,
 
                                          SULLIVAN & CROMWELL

<PAGE>
                                                                    EXHIBIT 23.1
 
                       CONSENT OF INDEPENDENT ACCOUNTANTS
 
    We consent to the inclusion in this registration statement of Commonwealth
Industries, Inc. on Form S-3 of our report dated February 11, 1997, on our
audits of the consolidated financial statements of Commonwealth Aluminum
Corporation. We also consent to the reference to our firm under the caption
"Experts."
 
                                          COOPERS & LYBRAND L.L.P.
 
   
Louisville, Kentucky
September 17, 1997
    

<PAGE>
                                                                    EXHIBIT 23.2
 
                        CONSENT OF INDEPENDENT AUDITORS
 
We consent to the reference to our firm under the caption "Experts" in Amendment
No. 2 to the Registration Statement (Form S-3 No. 333-32541) and related
Prospectus of Commonwealth Industries, Inc. for the registration of 5,750,000
shares of its common stock and to the incorporation by reference therein of our
report dated May 10, 1996, with respect to the consolidated financial statements
of CasTech Aluminum Group Inc. included in the Current Report (Form 8-K) of
Commonwealth Aluminum Corporation filed September 26, 1996 with the Securities
and Exchange Commission.
 
                                          ERNST & YOUNG LLP
 
Akron, Ohio
September 17, 1997


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission